SEARCH ARTICLES



LATEST ARTICLES

Table of Contents

2019 Month : September Volume : 8 Issue : 35 Page : 2733-2737

Cardiac Autonomic Neuropathy- An ECG Correlation in Type 2 Diabetes.

Subashini Vijayan1, Ganesamoorthy K.2, Usha Padmini3, Ravikumar T.4

1Assistant Professor, Department of Medicine, Government Medical College and ESI Hospital, Coimbatore, Tamilnadu, India. 2Associate Professor, Department of Medicine, Government Medical College and ESI Hospital, Coimbatore, Tamilnadu, India. 3Associate Professor, Department of Medicine, Government Medical College and ESI Hospital, Coimbatore, Tamilnadu, India. 4Professor and HOD, Department of Medicine, Government Medical College and ESI Hospital, Coimbatore, Tamilnadu, India.

References :

1

Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev 1994;10(4):339-83.       

Google Scholar | PubMed
2

Sivieri R, Veglio M, Chinaglia A, et al. Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. The Neuropathy Study Group of the Italian Society for the Study of Diabetes. Diabet Med 1993;10(10):920-4.      

Google Scholar | PubMed
3

Pfeifer MA, Weinberg CR, Cook DL, et al. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 1984;7(5):447-53.          

CrossRef | Google Scholar | PubMed
4

Sacre JW, Franjic B, Jellis CL, et al. Association of cardiac autonomic neuropathy with subclinical myocardial Dysfunction in type 2 diabetes. J Am Coll Cardiol Img 2010;3(12):1207-15.                      

CrossRef | Google Scholar | PubMed
5

Whitsel EA, Boyko EJ, Siscovick DS. Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis. Diabetes Care 2000;23(2):241-7.               

CrossRef | Google Scholar | PubMed
6

Veglio M, Borra M, Stevens LK, et al. The relation between QTc interval prolongation and diabetic complications: The EURODIAB IDDM Complications Study Group. Diabetologia 1999;42(1):68-75.            

CrossRef | Google Scholar | PubMed
7

Vinik AI, Maser RE, Mitchell BD, et al. Diabetic autonomic neuropathy. Diabetes Care 2003;26(5):1553-79.          

CrossRef | Google Scholar | PubMed
8

Ewing DJ, Martyn CN, Young RJ, et al. The value of cardiovascular autonomic function tests: 10 years of experience in diabetes. Diabetes Care 1985;8(5):491-8.              

CrossRef | Google Scholar | PubMed
9

Kahn R. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Autonomic nervous system testing. Diabetes Care 1992;15(8):1095-103.            

PubMed
10

Takebayashi K, Aso Y, Sugita R, et al. Clinical usefulness of corrected QT intervals in diabetic autonomic neuropathy in patients with type 2 diabetes. Diabetes Metab 2002;28(2):127-32.           

Google Scholar | PubMed
11

Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007;115(3):387-97.              

CrossRef | Google Scholar | PubMed
12

Pappachan JM, Varughese GI, Sriraman R, et al. Diabetic cardiomyopathy: pathophysiology, diagnostic evaluation and management. World J Diabetes 2013;4(5):177-89.   

CrossRef | Google Scholar | PubMed
13

Vinik AI, Erbas T. Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 2001;68(11):928-30, 932, 934-44.     

Google Scholar | PubMed